Skip to main content
. Author manuscript; available in PMC: 2017 Oct 1.
Published in final edited form as: Mol Cancer Ther. 2016 Aug 2;15(10):2541–2550. doi: 10.1158/1535-7163.MCT-16-0051

Figure 3. J591-conjugate circulating half-life.

Figure 3

15 μg of each of the three J591-conjugates were injected via tail vein (N=5 per group). Blood samples were collected by glass microcapillary at indicated times and quantified by 800 nm NIR fluorescent imaging. Results represent percent injected dose remaining in circulation, relative to the first time point. Error bars indicate standard deviation of the mean.